{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:30:18Z","timestamp":1787243418420,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The COVID-19 pandemic is still a public health concern in South Sudan having caused suffering since the first case of COVID-19 was introduced on 28\n                      <jats:sup>th<\/jats:sup>\n                      February 2020. COVAX vaccines have since been introduced using a number of strategies including fixed site, temporary mobile, hit and run in flooded and conflict affected areas. We aim to describe the 2 ICVOPT campaigns that were conducted to improve the uptake and document lessons learnt during the initial rollout of the COVID-19 vaccination programin South Sudan between February 2022 and June 2022 each lasting for 7-days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>We conducted an operational cross-sectional descriptive epidemiological study of a series of the intensified COVID-19 vaccination Optimization (ICVOPT) campaigns from February 2022 to June 2022. Before the campaign, a bottom up micro-planning was conducted, validated by the County Health Departments (CHDs) and national MOH team. Each of the 2 campaigns lasted for 7 days targeting 30% of the eligible unvaccinated target population who were18 years and above. Each team consisted of 2 vaccinators, 2 recorders and 1 mobilizer. The teams employed both fixed site, temporary mobile, hit and run in flooded and conflict affected areas. The number of teams were calculated based on the daily workload per day (80 persons per team\/day) for the duration of the campaigns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 444,030 individuals were vaccinated with primary series COVID-19 vaccine (J&amp;J) out of the targeted 635,030 persons. This represented 69.9% of target population in the selected 28 counties and 10 states of South Sudan in 7 days\u2019 ICVOPT campaigns. More eligible persons were reached in 7 days campaigns than the 9 months of rollout of the COVID-19 vaccine prior to ICVOPT campaigns using the fixed site strategy at the health facility posts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intensified COVID-19 vaccination Optimization (ICVOPT) campaigns were vital and fast in scaling up vaccination coverages as compared to the fixed site vaccination strategies (2022 progress report on the Global Action Plan for Healthy Lives and Well-being for All Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals, incentivizing collaboration, 2022) in complex humanitarian emergency settings and hard-to-reach areas of South Sudan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09371-4","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:03:03Z","timestamp":1717063383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cImplementation of intensified COVID-19 vaccination optimization (ICVOPT) campaigns strategy in complex humanitarian emergency settings and hard-to-reach areas; a case of South Sudan\u201d"],"prefix":"10.1186","volume":"24","author":[{"given":"Dickens","family":"Atwongyeire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesheshem Ademe","family":"Tegegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Ndenzako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anson Edu","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benz","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferede","family":"Melesachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"George Bachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Baguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"9371_CR1","doi-asserted-by":"crossref","unstructured":"Lone SA, Ahmad A. COVID-19 pandemic\u2013an African perspective. Emerging Microbes and Infections. Volume 9. Taylor and Francis Ltd; 2020. pp. 1300\u20138.","DOI":"10.1080\/22221751.2020.1775132"},{"issue":"4","key":"9371_CR2","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2213-2600(21)00129-6","volume":"9","author":"TK Burki","year":"2021","unstructured":"Burki TK. Challenges in the rollout of COVID-19 vaccines worldwide. Lancet Respir Med. 2021;9(4):e42\u201343.","journal-title":"Lancet Respir Med"},{"key":"9371_CR3","unstructured":"WHO\u2019s Strategic Preparedness, Readiness and Response Plan to End COVID-19 pandemic."},{"issue":"9","key":"9371_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293\u2013302.","journal-title":"Lancet Infect Dis"},{"key":"9371_CR5","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1017\/S0950268822001212","volume":"150","author":"B Impouma","year":"2022","unstructured":"Impouma B, Mboussou F, Farham B, Makubalo L, Mwinga K, Onyango A, et al. COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward. Epidemiol Infect. 2022;150:e143.","journal-title":"Epidemiol Infect"},{"key":"9371_CR6","unstructured":"Lieberman A. Humanitarians plan for COVID-19 vaccinations in conflict zones\u00a0devex.com\/news\/humanitarians-plan-for-covid-19-vaccinations-in-conflict-zones-98971. 2021."},{"key":"9371_CR7","unstructured":"What\u2019s In Blue Briefing on COVID-19 Vaccines in Conflict and Humanitarian Settings. Available from: https:\/\/www.securitycouncilreport.org\/whatsinblue\/2022\/04\/briefing-on-covid-19-vaccines-in-conflict-and-humanitarian-settings.php?print=true."},{"issue":"3","key":"9371_CR8","doi-asserted-by":"publisher","first-page":"e0000192","DOI":"10.1371\/journal.pgph.0000192","volume":"2","author":"A Warsame","year":"2022","unstructured":"Warsame A, Fuje M, Checchi F, Blanchet K, Palmer J. Evaluating COVID-19 decision-making in a humanitarian setting: the case study of Somalia. PLOS Global Public Health. 2022;2(3):e0000192.","journal-title":"PLOS Global Public Health"},{"issue":"11","key":"9371_CR9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/vaccines10111965","volume":"10","author":"P Immordino","year":"2022","unstructured":"Immordino P, Graci D, Casuccio A, Restivo V, Mazzucco W. COVID-19 vaccination in migrants and refugees: lessons learnt and good practices. Vaccines (Basel). 2022;10(11):1965.","journal-title":"Vaccines (Basel)"},{"key":"9371_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17165893","volume":"17","author":"J French","year":"2020","unstructured":"French J, Deshpande S, Evans W, Obregon R. Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy. International Journal of Environmental Research and Public Health. 2020;17:1\u201314 (MDPI AG).","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"9371_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41591-021-01328-3","volume":"27","author":"M Zard","year":"2021","unstructured":"Zard M, Lau LS, Bowser DM, Fouad FM, Lucum\u00ed DI, Samari G, et al. Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations. Nat Med. 2021;27:747\u20139 (Nature Research).","journal-title":"Nat Med"},{"key":"9371_CR12","doi-asserted-by":"crossref","unstructured":"Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Vol. 11, \u2022GERMS. 2021. Available from:\u00a0www.germs.ro.","DOI":"10.18683\/germs.2021.1280"},{"key":"9371_CR13","unstructured":"COVID-19 immunization in refugees and migrants: principles and key considerations."},{"key":"9371_CR14","unstructured":"Rapid Review. Vaccine hesitancy and building confidence in COVID-19 vaccination."},{"issue":"13","key":"9371_CR15","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.3201\/eid2813.212123","volume":"28","author":"HM Soeters","year":"2022","unstructured":"Soeters HM, Doshi RH, Fleming M, Adegoke OJ, Ajene U, Aksnes BN, et al. CDC\u2019s COVID-19 international vaccine implementation and evaluation program and lessons from earlier vaccine introductions. Emerg Infect Dis. 2022;28(13):S208\u2013216.","journal-title":"Emerg Infect Dis"},{"key":"9371_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/pubmed\/fdaa068","volume":"42","author":"A Ekzayez","year":"2020","unstructured":"Ekzayez A, al-Khalil M, Jasiem M, Al Saleh R, Alzoubi Z, Meagher K, et al. Perspectives COVID-19 response in Northwest Syria: Innovation and community engagement in a complex conflict. J Public Health (Oxf). 2020;42:504\u20139 (Oxford University Press).","journal-title":"J Public Health (Oxf)"},{"key":"9371_CR17","unstructured":"Considerations. for integrating COVID-19 vaccination tnto immunization programmes and primary health care for 2022 and beyond."},{"key":"9371_CR18","unstructured":"2022 progress report on the Global Action Plan for Healthy Lives and Well-being for All Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals, incentivizing collaboration. 2022. http:\/\/apps.who.int\/bookorders."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09371-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09371-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09371-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:03:08Z","timestamp":1717063388000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09371-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9371"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09371-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this involved review of reports and dashboards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"544"}}